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Abstract Obesity is associated with blunted β-adrenoreceptor (β-AR)-mediated lipolysis and lipid 
oxidation in adipose tissue, but the mechanisms linking nutrient overload to catecholamine resistance 
are poorly understood. We report that targeted disruption of TGF-β superfamily receptor ALK7 
alleviates diet-induced catecholamine resistance in adipose tissue, thereby reducing obesity in mice. 
Global and fat-specific Alk7 knock-out enhanced adipose β-AR expression, β-adrenergic signaling, 
mitochondrial biogenesis, lipid oxidation, and lipolysis under a high fat diet, leading to elevated energy 
expenditure, decreased fat mass, and resistance to diet-induced obesity. Conversely, activation of 
ALK7 reduced β-AR-mediated signaling and lipolysis cell-autonomously in both mouse and human 
adipocytes. Acute inhibition of ALK7 in adult mice by a chemical-genetic approach reduced diet-
induced weight gain, fat accumulation, and adipocyte size, and enhanced adipocyte lipolysis and 
β-adrenergic signaling. We propose that ALK7 signaling contributes to diet-induced catecholamine 
resistance in adipose tissue, and suggest that ALK7 inhibitors may have therapeutic value in human 
obesity.
DOI: 10.7554/eLife.03245.001
Introduction
Agonists of β3-adrenoceptors (β3-AR) are effective anti-obesity agents in rodents due to their ability 
to stimulate lipolysis and lipid oxidation in adipose tissue (Arch, 2011). However, efforts to develop 
similar compounds in humans stalled when it became clear that the pharmacology of rodent and 
human β3-AR differed and lipolysis in human adipocytes was mainly mediated by classical β1- and β2-
AR, which can also induce hypertension, tachycardia, and other undesired complications (Arch, 2011). 
Alternative strategies to enhance catecholamine sensitivity and β-adrenergic signaling selectively in 
adipose tissue may be effective in combating obesity, but remain unproven. In both humans and 
rodents, obesity is associated with blunted β-AR-mediated lipolysis and lipid oxidation in adipose 
tissue (Reynisdottir et al., 1994; Arner, 1999; Jocken et al., 2008), but the mechanisms linking nutrient 
overload to catecholamine resistance remain poorly understood.
ALK7 is a receptor for a subset of ligands from the TGF-β superfamily, including Nodal, activin B, 
and GDF-3 (Rydén et al., 1996; Reissmann et al., 2001; Tsuchida et al., 2004; Andersson et al., 
2008). ALK7 is not necessary for mouse embryogenesis (Jörnvall et al., 2004), suggesting alternative 
functions in postnatal development and adult physiology. ALK7 is highly expressed in rodent and 
human adipose tissue (Kang and Reddi, 1996; Andersson et al., 2008; Carlsson et al., 2009; 
Murakami et al., 2012), as well as in a few other tissues implicated in metabolic regulation, such as 
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pancreatic islets (Bertolino et al., 2008) and the arcuate nucleus of the hypothalamus (Sandoval-
Guzmán et al., 2012). Mice lacking ALK7 show reduced fat accumulation after a high fat diet 
(Andersson et al., 2008) and in a polygenic model of obesity (Yogosawa et al., 2013), but the mecha-
nisms underlying the effects of ALK7 signaling on diet-induced obesity are not understood. Pancreatic 
islets from Alk7 knock-out mice show enhanced glucose-stimulated insulin secretion (Bertolino et al., 
2008), a phenotype that is also present in islets from mutant mice lacking the ALK7 ligand activin 
B (Wu et al., 2014). Moreover, the arcuate nucleus of Alk7 knock-out mice shows reduced expression 
of Npy mRNA and lower numbers of Npy-expressing neurons compared to wild type controls 
(Sandoval-Guzmán et al., 2012). It has therefore been unclear whether ALK7 affects fat accumulation 
cell-autonomously in adipose tissue or through other sites, and whether its effects on adult physiology 
are developmental or homeostatic, via acute regulation of adult cell function.
In this study, we developed a conditional knock-out mouse lacking ALK7 in adipose tissue and 
a knock-in mouse model carrying an analogue-sensitive kinase allele (ASKA) of ALK7, which can be 
specifically inhibited by administration of ATP competitive inhibitors. Using these animals, as well as 
cell culture models, we have established that ALK7 functions cell-autonomously and acutely in adult 
adipocytes to control energy expenditure and fat accumulation by suppressing adipocyte mitochon-
drial biogenesis, fatty acid oxidation, and β-AR mediated-lipolysis. Importantly, we found that ALK7 
eLife digest Adrenaline and noradrenaline are two hormones that trigger the burst of energy 
and increase in heart rate and blood pressure that are needed for the ‘fight-or-flight’ response. 
Both belong to a group of chemicals called catecholamines. These chemicals bind to cells carrying 
proteins called adrenoceptors on their surface and stimulate the breakdown of fat, which releases 
energy. However, when nutrients are plentiful, fat cells become resistant to catecholamines and 
instead store fat so it can be used for energy if food becomes scarce. In the industrialized world 
where food is easily and constantly accessible, this resistance can cause an unhealthy increase in 
body fat and result in obesity.
Increasing fat metabolism by making fat cells more able to respond to catecholamines is an 
attractive strategy for combating obesity. Indeed, drugs that mimic the effect of catecholamines on 
an adrenoceptor found in mice reduce obesity caused by over-eating. However, these drugs are 
ineffective in humans and can cause harmful side effects to the cardiovascular system, including high 
blood pressure and an increased heart rate. Devising a strategy that specifically targets catecholamine 
resistance in fat cells is therefore desirable.
A protein called ALK7 is a cell surface receptor that is predominantly found in fat cells and tissues 
involved in controlling the metabolism. Mice with a mutation in ALK7 that stops this protein from 
working properly accumulate less fat than mice with a functional version of the protein, but it is not 
known why. To understand ALK7's involvement in fat metabolism, Guo et al. created mice whose fat 
cells lack ALK7, but whose other cells all produce ALK7 as normal. When fed a diet rich in fat, these 
mice are leaner than regular mice and they burn more energy.
The metabolic responses seen in ALK7 mutant mice are very similar to those seen in mice 
treated with drugs targeting adrenoceptors, suggesting that there may be a link between ALK7 
and catecholamine resistance. Indeed, Guo et al. demonstrate that fat cells lacking ALK7 have an 
increased sensitivity to catecholamines when the mice are on a high fat diet, which decreases the 
amount of fat the mice accumulate. Conversely, increasing the activity of ALK7 reduces the ability of 
the cells to respond to catecholamines, and they accumulate more fat.
Guo et al. also generated a second line of mice carrying a mutation in ALK7 that does not affect 
its function, but renders it sensitive to inhibition by a custom-made chemical. When these animals 
were on a high-fat diet, administering the chemical made the mice leaner, suggesting that inhibiting 
the ALK7 receptor can prevent obesity in adult animals.
Guo et al. also performed experiments in human fat cells, which showed that the ALK7 receptor 
works in a similar way in human cells as it does in mice. As ALK7 is largely specific for fat cells and is 
not known to affect the cardiovascular system, drugs that inhibit ALK7 could potentially safely suppress 
catecholamine resistance and reduce human obesity.
DOI: 10.7554/eLife.03245.002
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signaling negatively regulates adipocyte β-AR expression and β-adrenergic signaling during a high fat 
diet, providing a link between nutrient overload and catecholamine resistance in adipose tissue.
Results
Fat-specific disruption of ALK7 signaling attenuates weight gain and fat 
accumulation under a high fat diet
In order to dissect the cell-autonomous functions of ALK7 in specific tissues, we generated a conditional 
knock-out allele of the mouse Alk7 gene (also known as Acvr1c) with loxP sites flanking exons 5 and 6, 
encoding essential regions of the ALK7 kinase domain (Figure 1—figure supplement 1). Gene deletion 
in adipose tissue was achieved by crossing Alk7fx mice with Ap2CRE mice (He et al., 2003). Although 
Ap2CRE has also been reported to be expressed in adipose tissue macrophages (Lee et al., 2013), Alk7 
mRNA expression could only be detected in the adipocyte fraction of adipose tissue but not in the 
stromal-vascular fraction (containing macrophages) or in spleen (Figure 1—figure supplement 2A–D). 
Expression of Alk7 mRNA was reduced by 60% in the adipose tissue of Alk7fx/fx::Ap2CRE mice, while a 
98% reduction was achieved in Alk7fx/−::Ap2CRE mice (i.e., compound heterozygotes carrying floxed 
and knock-out Alk7 alleles) (Figure 1—figure supplement 3A,B). No change in Alk7 mRNA expression 
was observed in the pancreas or brain (Figure 1—figure supplement 2B). Both lines of fat-specific 
Alk7 mutant mice showed significantly reduced weight gain during 12 weeks on a high fat diet compared 
to controls (Figure 1A,B). In contrast, weight gain in Alk7fx/fx::NestinCRE mice, lacking ALK7 expression 
in the nervous system (Figure 1—figure supplement 3C), did not differ from controls (Figure 1C). 
Diet-induced fat accumulation, as measured by epididymal and retroperitoneal fat depot weight 
(Figure 1D–F), magnetic resonance imaging (MRI) of total fat mass (Figure 1G,H), and adipocyte cell 
size (Figure 1I,J), was also significantly reduced in fat-specific Alk7 mutant mice compared to controls. 
In contrast, fat depots of nervous system-specific Alk7 mutant mice were not different from controls 
(Figure 1K). In agreement with reduced diet-induced obesity, serum leptin levels were also lower after 
a high fat diet in both global and fat-specific Alk7 knock-out mice (Figure 2A,B). However, fed serum 
insulin levels remained unchanged in fat-specific and brain-specific Alk7 knock-out mice (Figure 2C,D), 
suggesting unaltered peripheral insulin sensitivity. In addition, glucose and insulin tolerance tests per-
formed in fat-specific Alk7 mutant mice and controls indicated normal glucose and insulin responses 
in the mutants (Figure 2E–H). Obesity has been associated with a state of inflammation in adipose 
tissue in which resident macrophages play important roles (Hotamisligil, 2006; Fujisaka et al., 2009). 
Following 8 weeks of a high fat diet, adipose tissue of global and fat-specific Alk7 knock-out mice 
showed decreased expression of markers of pro-inflammatory M1 macrophages, such as TNF1α, IL-12b, 
and Itgax (Figure 2I,J), but increased expression of Mgl2, a marker of M2 macrophages, the major 
resident macrophages involved in remodeling and repair that are normally present in adipose tissue 
from lean mice (Figure 2K,L). This profile is in agreement with reduced adipose tissue inflammation 
and protection against diet-induced obesity. Together, these results indicate that ALK7 functions cell-
autonomously in adipose tissue to regulate fat accumulation during nutrient overload.
Increased energy expenditure and adipose tissue mitochondrial 
biogenesis in fat-specific Alk7 knock-out mice on a high fat diet
The reduced obesity in Alk7 knock-out mice after a high fat diet could be a result of lower calorie 
intake or higher energy expenditure. Both global knock-out and fat-specific Alk7 mutant mice displayed 
increased energy expenditure (Figure 3A,B) and oxygen consumption (Figure 3C,D) after a high fat 
diet compared to controls. Food intake remained unchanged in the mutant mice (Figure 3E). Changes 
in energy expenditure in Alk7 mutant mice were not due to ‘browning’ of subcutaneous adipose 
tissue, as expression of brown adipose tissue (BAT) marker genes Ucp1 and Elovl3 was not increased 
in the subcutaneous fat of the mutants (Figure 3—figure supplement 1A,B). Moreover, the browning 
effects of the β3-AR-specific agonist CL316243 were comparable in subcutaneous adipose tissue of 
wild type and Alk7 knock-out mice (Figure 3—figure supplement 1C,D). Neither was expression of 
BAT markers elevated in the BAT of Alk7 mutant mice (data not shown). Global and fat-specific Alk7 
knock-out mice showed higher physical activity than wild type controls after a high fat diet (Figure 3F,G). 
However, it was recently reported that changes in activity do not drive changes in energy expenditure 
in groups of mice below thermoneutrality (Virtue et al., 2012). We hypothesized that increased 
energy expenditure in Alk7 mutant mice on a high fat diet may be due to higher basal metabolic rate, 
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and investigated adipose tissue mitochondria biogenesis and function, which are impaired by chronic 
nutrient overload in rodents and humans (Heilbronn et al., 2007; Rong et al., 2007; Sutherland 
et al., 2008). Mitochondria biogenesis, as measured by mitochondrial DNA content (Figure 4A,B), 
citrate synthase activity (Figure 4C,D), and ATP content (Figure 4E,F), was significantly increased 
in adipose tissue of both global and fat-specific Alk7 knock-out mice on a high fat diet compared to 
controls. In addition, several markers of mitochondrial biogenesis and function were also significantly 
Figure 1. Conditional deletion of ALK7 in adipose tissue attenuates weight gain and fat deposition under a high fat diet. (A–C) Weight gain under chow 
(squares) and a high fat diet (HFD, triangles) in fat-specific Alk7fx/fx::Ap2CRE (A) and Alk7fx/−::Ap2CRE (B), and brain-specific Alk7fx/fx::NestinCRE (C) knock-out 
mice (solid symbols) compared to control mice (open symbols). Arrows denote the first week of HFD. N = 8 mice per group in all cases, except N = 6 in 
(C) on a chow diet. (D–F) Weights of epididymal (Epi) and retroperitoneal (Retro) fat depots in global Alk7−/− (D) and fat-specific Alk7fx/fx::Ap2CRE (E) 
and Alk7fx/−::Ap2CRE (F) knock-out mice after 16 weeks on HFD. N = 6 mice per group. (G and H) Fat and lean mass assessed by magnetic resonance 
imaging (MRI) in global Alk7−/− (G) and fat-specific Alk7fx/−::Ap2CRE (H) knock-out mice after 16 weeks on HFD. N = 8 mice per group in (G), N = 5 in (H). 
(I and J) Adipocyte cell size in fat-specific Alk7fx/−::Ap2CRE knock-out mice and Alk7fx/− controls after chow or HFD as visualized by hematoxylin-eosin staining 
in tissue sections of epididymal adipose tissue (I). Quantitative analysis is shown in (J). Small, 400–5000 μm2; Med, 5000–10,000 μm2; Large, 10,000–60,000 
μm2. N = 4 mice per group (four sections per mouse). (K) Weights of epididymal (Epi) and retroperitoneal (Retro) fat depots in brain-specific Alk7fx/fx::NestinCRE 
knock-out mice after 16 weeks on HFD. N = 6 mice per group. *p < 0.05; **p < 0.01; NS, non-significant (mutant vs control). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.003
The following figure supplements are available for figure 1:
Figure supplement 1. Generation of a conditional allele of the mouse Acvr1c gene encoding ALK7. 
DOI: 10.7554/eLife.03245.004
Figure supplement 2. Alk7 expression in adipocytes, but not in adipose tissue macrophages. 
DOI: 10.7554/eLife.03245.005
Figure supplement 3. Alk7 expression in conditional knock-out mice. 
DOI: 10.7554/eLife.03245.006
Human biology and medicine
Guo et al. eLife 2014;3:e03245. DOI: 10.7554/eLife.03245 5 of 18
Research article
upregulated in the mutants, including PGC-1α, a master regulator of mitochondrial biogenesis (Wu et al., 
1999), mitochondrial uncoupling protein 3 (UCP-3), cytochrome C, and Hadhb, a key mitochondrial 
enzyme for β-oxidation of long chain fatty acids (Middleton, 1994) (Figure 4G,H). In line with these 
changes, fatty acid oxidation activity was enhanced in the adipose tissue of global and fat-specific Alk7 
mutant mice (Figure 4I,J). These results suggest that resistance to diet-induced obesity in Alk7 mutant 
mice is due to increased energy expenditure and enhanced mitochondrial function and lipid oxidation 
in adipose tissue.
Enhanced catecholamine sensitivity and β-adrenergic signaling in adipose 
tissue of global and fat-specific Alk7 knock-out mice on a high fat diet
Activation of β-ARs by catecholamines is the major regulatory pathway of fat mobilization during star-
vation and exercise. Mice lacking all three types of β-ARs are massively obese on a high fat diet with-
out an increase in food intake (Bachman et al., 2002). Conversely, β-agonist treatment induces 
mitochondria biogenesis in adipose tissue and reduces fat mass (Ghorbani et al., 1997), resembling 
the phenotype observed in Alk7 mutant mice. β-AR-dependent fat mobilization is severely impaired 
during a high fat diet, allowing fat accumulation in adipose tissue, but the underlying mechanisms of 
Figure 2. Reduced serum leptin levels and adipose tissue inflammation but normal glucose and insulin metabolism in global and fat-specific Alk7 
knock-out mice. (A and B) Serum levels of leptin in global Alk7−/− (A) and fat-specific Alk7fx/fx::Ap2CRE (B) knock-out mice after 16 weeks on a high fat diet 
(HFD). N = 6 mice per group. (C and D) Serum levels of insulin in fat-specific Alk7fx/−::Ap2CRE (C) and brain-specific Alk7fx/fx::NestinCRE (D) knock-out mice 
after 16 weeks on HFD. N = 6 mice per group. (E and F) Blood glucose levels after glucose injection in 4-month-old Alk7fx/−::Ap2CRE mice and controls 
after chow (E) or a high fat diet (F). Mice had been starved overnight prior to glucose injection. N = 5 mice per group. (G) Serum insulin levels after 
glucose injection in 4-month-old Alk7fx/−::Ap2CRE mice and controls kept on a chow diet. Mice had been starved overnight prior to glucose injection.  
N = 5 mice per group. (H) Blood glucose levels after insulin injection in 4-month-old Alk7fx/−::Ap2CRE mice and controls kept on a chow diet. Mice had 
been starved for 3 hr prior to insulin injection. N = 5 mice per group. (I–L) Relative mRNA expression levels of M1 macrophage markers TNF1a, Itgax, 
and IL12b (I and J) and the M2 macrophage marker Mgl2 (K and L) assessed by quantitative PCR in epididymal adipose tissue of global Alk7−/− (I and K) 
and fat-specific Alk7fx/fx::Ap2CRE (J and L) knock-out mice after 16 weeks on HFD. N = 6 mice per group. *p < 0.05; **p < 0.01; NS, non-significant (mutant 
vs control). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.007
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catecholamine resistance have not been clarified (Reynisdottir et al., 1994; Jocken et al., 2008). 
We investigated whether ALK7 could play a role in the catecholamine sensitivity of adipose tissue 
under a low caloric diet and after nutrient overload. Under a chow diet, injection of the β3-AR-specific 
agonist CL316243 enhanced lipolysis, as measured by free fatty acid release, significantly more in fat-
specific Alk7 knock-out mice than in wild type controls (Figure 5A). After 16 weeks on a high fat diet, 
global and fat-specific Alk7 knock-out mice also displayed elevated lipolysis compared to controls 
under both basal conditions and following β3-AR stimulation (Figure 5B,C). On the other hand, we 
detected no change in basal or agonist-stimulated lipolysis in brain-specific Alk7 knock-out mice 
(Figure 5D). As levels of epinephrine and norepinephrine were not significantly altered in the adipose 
tissue of Alk7 knock-out mice (Figure 5—figure supplement 1), these data suggested enhanced cat-
echolamine sensitivity in adipose tissue lacking ALK7. In agreement with this, the levels of Adrb1 and 
Adrb3 mRNAs were significantly protected in Alk7 knock-out mice after 16 weeks on a high fat diet, 
but were barely detectable in the adipose tissue of control mice (Figure 5E,F). In addition, expression 
of the negative regulator of adrenergic signaling Rgs2, an inhibitor of adenylate cyclase, was elevated 
after a high fat diet in the adipose tissue of wild type mice but not in Alk7 knock-out mice (Figure 5G) 
or fat-specific Alk7 knock-out mice (Figure 5H,I). Adrb1 and Adrb3 mRNA levels were also significantly 
Figure 3. Increased energy expenditure and oxygen consumption in global and fat-specific Alk7 knock-out mice 
on a high fat diet. (A and B) Energy expenditure assessed by calorimetric measurements in global Alk7−/− (A) and 
fat-specific Alk7fx/−::Ap2CRE (B) knock-out mice after 16 weeks on a high fat diet (HFD). N = 8 mice per group in (A), 
N = 6 in (B). (C and D) Oxygen consumption assessed by calorimetric measurements in global Alk7−/− (C) and 
fat-specific Alk7fx/−::Ap2CRE (D) knock-out mice after 16 weeks on HFD. N = 8 mice per group in (C), N = 6 in (D). 
(E) Daily food intake in fat-specific Alk7fx/−::Ap2CRE knock-out mice during 16 weeks on HFD. N = 6 mice per group. 
(F and G) Physical activity assessed as ambulation in global Alk7−/− (F) and fat-specific Alk7fx/−::Ap2CRE (G) knock-out 
mice after 16 weeks on HFD. N = 8 mice per group in (F), N = 6 in (G). *p < 0.05; **p < 0.01; NS, non-significant 
(mutant vs control). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.008
The following figure supplement is available for figure 3:
Figure supplement 1. Alk7 deletion does not result in enhanced 'browning' of subcutanous adipose tissue. 
DOI: 10.7554/eLife.03245.009
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higher in fat-specific Alk7 knock-outs compared to controls after a high fat diet (Figure 5H,I). In line 
with enhanced adrenergic signaling, we observed increased levels of total and phosphorylated hormone-
sensitive lipase (HSL), a major target of the β-adrenergic pathway in adipocytes, and phosphorylated 
PKA substrates in the adipose tissue of Alk7 knock-out mice after 16 weeks on a high fat diet compared 
to wild type controls (Figure 5J,K). Moreover, norepinephrine injection induced a more pronounced 
increase in PKA activity in the adipose tissue of Alk7 knock-out mice than in control mice (Figure 5L). 
Together, these data suggest that cell-autonomous ALK7 signaling in adipose tissue suppresses cate-
cholamine sensitivity and β-adrenergic signaling under a high fat diet.
ALK7 signaling negatively regulates catecholamine sensitivity and 
β-adrenergic signaling in mouse and human adipocytes
The enhanced catecholamine sensitivity of adipose tissue in Alk7 mutant mice prompted us to investi-
gate the acute effects of ALK7 signaling on β-AR expression and adrenergic signaling in cultured adi-
pocyte cells derived by differentiation from mouse embryonic fibroblasts (MEFs). Stimulation of wild 
type adipocytes with the ALK7 ligand activin B reduced expression of Adrb2 and Adrb3 mRNAs as well 
as mRNA for the β-adrenergic target gene Hsl (Figure 6A). Activin B had no effect on adipocytes 
derived from Alk7 knock-out MEFs (Figure 6B), indicating that its effects on adipocyte gene expres-
sion were mediated by ALK7. Activin B also downregulated expression of mRNA encoding PPARγ, 
a master regulator of adipogenesis (Figure 6A). However, the effects of activin B on adipocyte Adrb 
mRNA expression are likely to be independent of PPARγ, since inhibition of PPARγ had no significant 
effect on Adrb3 mRNA levels and activin B could suppress Adrb3 mRNA expression even in the pres-
ence of the PPARγ inhibitor or the PPARγ agonist rosiglitazone (Figure 6—figure supplement 1). 
Conversely, the related ligand activin A, which does not stimulate ALK7 signaling, enhanced adipocyte 
Figure 4. Elevated adipose tissue mitochondrial biogenesis and activity in fat-specific Alk7 knock-out mice on a high fat diet. (A–F) Mitochondrial 
biogenesis assessed by measurements of mitochondrial (mito) DNA content (A and B), citrate synthase activity (C and D), and ATP content (E and F) in 
epididymal adipose tissue of global Alk7−/− (A, C, E) and fat-specific Alk7fx/−::Ap2CRE (B, D, F) knock-out mice after 16 weeks on a high fat diet (HFD).  
N = 8 mice per group in all cases. (G and H) Relative mRNA expression of markers of mitochondrial biogenesis and function PGC1a, Hadhb, UCP3, and 
cytochrome C assessed by quantitative PCR (Q-PCR) in epididymal adipose tissue of global Alk7−/− (G) and fat-specific Alk7fx/−::Ap2CRE (H) knock-out mice 
after 16 weeks on HFD. N = 6 mice per group in all cases. (I and J) Lipid oxidation in epididymal adipose tissue of global Alk7−/− (I) and fat-specific 
Alk7fx/−::Ap2CRE (J) knock-out mice. N = 3 mice per group in all cases. *p < 0.05; **p < 0.01; NS, non-significant (mutant vs control). All error bars show 
mean ± SEM.
DOI: 10.7554/eLife.03245.010
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Figure 5. Enhanced catecholamine sensitivity and β-adrenergic signaling in adipose tissue of global and fat-specific 
Alk7 knock-out mice on a high-fat diet. (A) Basal and CL316243 (CL)-stimulated serum free fatty acids (FFA) in 
fat-specific Alk7fx/−::Ap2CRE knock-out mice on a chow diet. N = 6 mice per group. (B–D) Basal and CL316243-
stimulated lipolysis in global Alk7−/− (B), fat-specific Alk7fx/fx::Ap2CRE (C), and brain-specific Alk7fx/fx::NestinCRE (D) 
knock-out mice after 16 weeks on a high fat diet (HFD). N = 6 mice per group. (E–G) Relative mRNA expression of 
Adrb1 (E), Adrb3 (F), and Rgs2 (G) assessed by Q-PCR in epididymal adipose tissue of global Alk7−/− knock-out mice 
on chow and after 1 week (wk) or 2 months (mo) on HFD. N = 6 mice per group. (H and I) Relative mRNA expression 
of Adrb1, Adrb3, and Rgs2 assessed by Q-PCR in epididymal adipose tissue of fat-specific Alk7fx/fx::Ap2CRE (H) and 
Alk7fx/−::Ap2CRE (I) knock-out mice after 16 weeks on HFD. N = 6 mice per group. (J and K) Levels of Adrb3, phospho-
HSL, total HSL, and phosphorylated PKA substrates assessed by Western blotting in epididymal adipose tissue of 
global Alk7−/− (J) and fat-specific Alk7fx/fx::Ap2CRE (K) knock-out mice after 16 weeks on HFD. The results shown are 
representative of four biological replicates. (L) Levels of phosphorylated PKA substrates were assessed by Western 
Figure 5. Continued on next page
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PPARγ mRNA expression but had no significant effect on Adrb2, Adrb3, and Hsl mRNA levels in wild 
type adipocytes (Figure 6C). Expression of Adrb2, Adrb3, and Hsl mRNAs was also significantly reduced 
in Alk7 knock-out adipocytes following ALK7 adenovirus-mediated overexpression (Figure 6D), which 
leads to ligand-independent receptor activation, showing that ALK7 is sufficient to suppress β-AR 
expression and signaling in adipocytes. In addition, activin B antagonized the stimulatory effects of 
blotting in epididymal adipose tissue from 2-month-old global Alk7−/− knock-out mice on a chow diet following 
injection of norepinephrine (NE) or vehicle (PBS). Results show the levels of phosphorylated PKA substrates 
quantified by image analysis after normalization to β-actin. N = 3 mice per group. *p < 0.05; **p < 0.01; NS, 
non-significant (mutant vs control). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.011
The following figure supplement is available for figure 5:
Figure supplement 1. Epinephrine and norepinephrine levels in adipose tissue of Alk7 knock-out mice after 
16 weeks on a high fat diet. 
DOI: 10.7554/eLife.03245.012
Figure 5. Continued
Figure 6. ALK7 signaling negatively regulates catecholamine sensitivity and β-adrenergic signaling in mouse and human adipocytes. (A) Relative mRNA 
expression of Adrb2, Adrb3, Hsl, and PPARg assessed by Q-PCR in adipocytes derived from wild type (WT) mouse embryonic fibroblasts (MEFs) 
following stimulation with activin B. N = 4 wells per condition. (B) Relative mRNA expression of Adrb2, Adbr3, PPARg, and Hsl assessed by Q-PCR in 
adipocytes derived from Alk7 knock-out MEFs after stimulation with activin B. N = 4 wells per condition. (C) Relative mRNA expression of Adrb2, Adbr3, 
PPARg, and Hsl assessed by Q-PCR in adipocytes derived from WT MEFs following stimulation with activin A. N = 4 wells per condition. (D) Relative 
mRNA expression of Alk7, Adrb2, Adrb3, and Hsl assessed by Q-PCR in adipocytes derived from WT MEFs following adenovirus-mediated ALK7 
overexpression. N = 4 wells per condition. (E) Levels of phospho-HSL and phospho-perilipin assessed by Western blotting in MEF-derived adipocytes 
after stimulation with β3-AR-specific agonist CL316243 (CL) or vehicle (veh) in the presence or absence of activin B (Act B). Independent biological 
duplicates are shown. (F) Assay of PKA activity in lysates of MEF-derived adipocytes after stimulation with β3-AR-specific agonist CL316243 (CL) or vehicle 
(veh) in the presence or absence of activin B (Act B). Independent biological duplicates are shown. (G and H) Basal and CL316243-stimulated lipolysis in 
MEF-derived adipocytes following stimulation with activin B (G) or adenovirus-mediated ALK7 overexpression (H). FFA: free fatty acids. N = 4 wells per 
condition. (I and J) Basal and isoproterenol (ISO)-stimulated lipolysis in human adipocytes following stimulation with activin B (I) or adenovirus-mediated 
ALK7 overexpression (J). N = 4 wells per condition. *p < 0.05; **p < 0.01; NS, non-significant (activin treatment vs vehicle or Adeno-Alk7 vs Adeno-LacZ, 
as indicated). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.013
The following figure supplement is available for figure 6:
Figure supplement 1. The effects of activin B on adipocyte Adrb mRNA expression are independent of PPARγ. 
DOI: 10.7554/eLife.03245.014
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the β3-AR agonist on the phosphorylation of HSL, perilipin, and PKA substrates in wild type adipocytes 
(Figure 6E,F). In line with these findings, activation of ALK7 signaling by either ligand or adenovirus-
mediated overexpression suppressed β-agonist induced lipolysis in wild type adipocytes (Figure 6G,H). 
Interestingly, both activin B and adenovirus-mediated ALK7 overexpression also suppressed β-agonist 
stimulated lipolysis in human adipocytes (Figure 6I,J). Together, these results indicate that acute activation 
of ALK7 is sufficient to suppress β-adrenergic signaling in both mouse and human adipocytes.
Acute inhibition of ALK7 signaling in adult mice through a chemical-
genetic approach prevents diet-induced catecholamine resistance and 
ameliorates obesity
Finally, we sought to determine whether acute blockade of ALK7 signaling in adult mice, by-passing 
possible developmental effects, could also enhance catecholamine sensitivity in adipose tissue and 
ameliorate diet-induced obesity. To this end, we devised a chemical-genetic approach to acutely inhibit 
the ALK7 kinase in adult mice using synthetic ATP analogues (Bishop et al., 1998, 2001). An analogue-
sensitive kinase allele of Alk7 (termed Alk7ASKA) was engineered by mutation of two residues in the 
active site of the ALK7 kinase. Substitution of the ‘gatekeeper’ residue Ser270 with Gly creates an extra 
pocket in the ALK7 active site, which can be further expanded by mutating the adjacent residue Leu250 
to Val. As assessed in transfected cells, the mutations had no effect per se on ligand-mediated signaling, 
but rendered the mutant receptor sensitive to inhibition by ATP competitive inhibitors, such as 2NaPP1 
(Figure 7—figure supplement 1). 2NaPP1 treatment did not affect signaling by the wild type ALK7 
receptor (Figure 7—figure supplement 1). Knock-in mice were generated carrying the two mutations 
in the Alk7 locus (Figure 7—figure supplement 2). Alk7ASKA mice developed normally, and displayed 
normal growth and normal fasting insulinemia and glycemia (data not shown). Activin B signaling was 
suppressed by 1NaPP1 (an isomer of 2NaPP1 with established in vivo stability [Savitt et al., 2012]) 
in adipocytes derived from Alk7ASKA homozygote mice but not from wild type controls (Figure 7A,B). 
Residual activin B activity in Alk7ASKA adipocytes treated with 1NaPP1 was likely due to expression of 
the related receptor ALK4, which can also respond to activin B by activating Smad3. We subjected 
cohorts of 2-month-old Alk7ASKA homozygote and wild type mice to a high fat diet together with twice 
daily injection of 30 mg/kg 1NaPP1 or vehicle, and monitored their weight daily during a period of 
2 weeks. Alk7ASKA and wild type mice gained weight at the same rate on a high fat diet, increasing by 
approximately 4 g by the end of the second week (Figure 7C,D). There was no weight gain on a 
chow diet for either genotype (Figure 7C,D). Injection of 1NaPP1 significantly reduced the weight 
gain rate in Alk7ASKA mice, which on average increased by only 1.6 g after 2 weeks on a high fat diet 
(Figure 7C). 1NaPP1 had no effect on wild type mice (Figure 7D). These results indicate that acute 
disruption of ALK7 signaling can protect adult mice from diet-induced obesity. Analogue treatment 
significantly reduced fat accumulation in epididymal and retroperitoneal adipose tissue depots in 
Alk7ASKA but not wild type mice (Figure 7E,F). Adipocyte cell size was also significantly reduced in 
Alk7ASKA mice treated with 1NaPP1 compared to vehicle (Figure 7G,H). We also observed enhanced 
induction of lipolysis by the β3-AR-specific agonist CL316243 in adipose tissue biopsies extracted 
from Alk7ASKA mice that had been treated with 1NaPP1 (Figure 8A). Moreover, treatment with 1NaPP1 
increased the levels of Adrb3 mRNA in epididymal and retroperitoneal adipose tissue of Alk7ASKA mice 
on a high fat diet (Figure 8B). In line with enhanced catecholamine sensitivity, 1NaPP1 treatment atten-
uated the suppressive effects of a high fat diet on adrenergic signaling in adipose tissue of Alk7ASKA 
mice, as assessed by the levels of phosphorylated HSL and PKA substrates (Figure 8C–E). Together, 
these data indicated that acute disruption of ALK7 signaling in adult mice can uncouple nutrient 
overload from catecholamine resistance in adipose tissue, resulting in reduced fat accumulation and 
decreased weight gain on a high fat diet.
Discussion
In mice and humans, nutrient overload induces catecholamine resistance in adipose tissue, thereby 
suppressing lipolysis and fatty acid oxidation, and enhancing fat accumulation. This is an efficient 
adaptive mechanism for energy storage during times of abundant food supply, enhancing survival 
upon starvation. In the modern industrialized world, however, the effortless availability of foods with 
high caloric content, together with reduced physical activity, has resulted in an obesity pandemic. 
Remarkably, the mechanisms linking nutrient overload to catecholamine resistance in adipose tissue 
are not well understood. Clarifying these mechanisms is important, as selective enhancement of 
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Figure 7. Acute inhibition of ALK7 signaling in adult mice through a chemical-genetic approach reduces diet-induced 
weight gain and fat accumulation. (A and B) Activin B signaling was assessed by p-Smad3 nuclear translocation 
in mouse embryonic fibroblast (MEF)-derived adipocytes from wild type (WT) or Alk7ASKA (Aska) mice in the 
presence and absence of ATP competitive inhibitor 1NaPP1. Nuclear p-Smad3 (red) was specifically evaluated by 
Figure 7. Continued on next page
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catecholamine sensitivity and β-adrenergic signaling in adipose tissue could be useful in the treatment 
of obesity. Obesity is thought to induce catecholamine resistance in adipose tissue by downregulating 
β-AR expression and interfering with downstream β-adrenergic signaling pathways, such as PKA activity 
(Reynisdottir et al., 1994; Arner, 1999; Jocken et al., 2008). Our results demonstrate that ALK7 
signaling contributes to catecholamine resistance by limiting both β-AR expression and signaling in 
adipocytes during a high fat diet. Signaling pathways are known to be regulated by negative feedback 
loops that limit intracellular responses upon sustained stimulation. Adrenergic signaling in adipose tissue 
self-attenuates under a high fat diet through PKA-mediated upregulation of Rgs2 (Song et al., 2010). 
Interestingly, a mutation in the Rgs2 promoter that increases Rgs2 expression has been shown to enhance 
susceptibility to metabolic syndrome in humans (Freson et al., 2007). However, it is unclear how elevated 
levels of Rgs2 can be sustained in adipose tissue during persistent catecholamine resistance. In our 
studies, disruption of ALK7 in adipose tissue largely prevented the upregulation of Rgs2 under a high 
fat diet, suggesting that ALK7 signaling may contribute to the maintenance of diet-induced Rgs2 
expression, possibly by cooperating with intermediate regulators, such as Crtc3 (Song et al., 2010).
Our studies in fat-specific Alk7 knock-out mice and Alk7ASKA knock-in mice demonstrate that ALK7 
functions cell-autonomously and homeostatically in adult adipocytes to regulate catecholamine sensi-
tivity in response to the diet. Adipocytes lacking ALK7 retain significant levels of β-AR expression and 
adrenergic signaling, allowing sustained lipid catabolism and increased energy expenditure. Although 
such a short-circuit would clearly be maladaptive upon starvation, it offers a therapeutic opportunity 
for the treatment of obesity. The fact that activin B and adenovirus-mediated ALK7 overexpression sup-
pressed β-agonist stimulated lipolysis in human adipocytes suggests functional conservation of the ALK7 
signaling pathway in human diet-induced obesity. A high fat diet and obesity increase adipocyte expres-
sion of the two main ALK7 ligands activin B and GDF-3 (Witthuhn and Bernlohr, 2001; Sjöholm et al., 
2006; Hoggard et al., 2009), suggesting enhanced ALK7 signaling in obesity. In line with this, diet-
induced obesity elevates the level of activated phospho-Smad3 in mouse adipose tissue (Yadav et al., 
2011). Mouse and human Alk7 mRNA expression is highest in adipose tissue, but undetectable in heart, 
liver or muscle (Kang and Reddi, 1996; Rydén et al., 1996; Carlsson et al., 2009; Murakami et al., 
2012). Thus, modulation of ALK7 signaling may offer an alternative approach to regulate catecholamine 
sensitivity and β-adrenergic signaling specifically and selectively in adipose tissue. We propose that ALK7 
represents a novel link between nutrient overload and catecholamine resistance in adipose tissue, and 
suggest that strategies to suppress ALK7 signaling may be beneficial to combat human obesity.
Materials and methods
Animals
Mice were housed under a 12 hr light–dark cycle, and fed a standard chow diet or a high fat diet 
(HFD, 60% of calorie from fat; ResearchDiet). The following transgenic mouse lines were used for 
immunohistochemistry in adipocytes, identified by BODIPY 493/503 staining (green). Representative photomicrographs 
are shown in (A). Scale bar, 50 μm. Quantitative analysis is shown in (B). N = 3 independent experiments each 
performed in triplicate. (C and D) Weight gain on chow (squares) and a high fat diet (HFD, triangles) in Alk7ASKA (C) 
and wild type (D) mice treated with 1NaPP1 (solid triangles) or vehicle (open squares and triangles). N = 6 mice per 
group in (C), N = 9 in (D). (E and F) Weights of epididymal (Epi) and retroperitoneal (Retro) fat depots in Alk7ASKA (E) 
and wild type (F) mice after chow (open bars) or 2 weeks on HFD treated with 1NaPP1 (black bars) or vehicle (gray 
bars). N = 6 mice per group in (E), N = 7 in (F). (G and H) Adipocyte cell size in Alk7ASKA mice after chow or HFD as 
visualized by hematoxylin-eosin staining in tissue sections of epididymal adipose tissue of Alk7ASKA mice after chow 
or 2 weeks on HFD treated with 1NaPP1 or vehicle (veh) (G). Quantitative analysis is shown in (H). Small, 400–5000 μm2; 
Med, 5000–10,000 μm2; Large, 10,000–20,000 μm2. N = 4 mice per group (four sections per mouse). *p < 0.05; 
**p < 0.01; NS, non-significant (1NaPP1 vs vehicle). All error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.015
The following figure supplements are available for figure 7:
Figure supplement 1. Validation of Alk7ASKA allele in transfected R4-2 cells. 
DOI: 10.7554/eLife.03245.016
Figure supplement 2. A chemical-genetic approach for acute inactivation of ALK7 in adult mice. 
DOI: 10.7554/eLife.03245.017
Figure 7. Continued
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experiments: Alk7 knock-out (Jörnvall et al., 2004), 
Ap2CRE (He et al., 2003), NestinCRE (Tronche et al., 
1999), Alk7fx conditional knock-out (this study), 
and Alk7ASKA knock-in (this study). The Alk7fx condi-
tional knock-out allele was generated by inserting 
loxP sites flanking exons 5 and 6 (Figure 1—figure 
supplement 1). Fat-specific knock-out lines were 
generated by crossing Alk7fx or Alk7fx/ to Ap2CRE. 
Brain-specific knock-out lines were generated by 
crossing Alk7fx to NestinCRE. The Alk7ASKA knock-in 
allele was generated by introducing L250V and 
S270G mutations into the Alk7 gene exons 4 and 5, 
respectively (Figure 7—figure supplement 2). 
Targeting vectors were generated using BAC clones 
from the C57BL/6J RPCIB-731 BAC library and 
transfected into the TaconicArtemis C57BL/6N Tac 
ES cell line. Gene-targeted mice were generated at 
TaconicArtemis (Germany) by standard methods. 
Animal experiments were approved by Stockholm 
North Ethical Committee for Animal Research.
Body composition and whole-body 
energy homeostasis
Fat and lean mass were measured using a body 
composition analyzer (EchoMRI Medical System, 
Houston, TX, USA). Indirect calorimetry, food intake, 
and locomotor activity were determined using a 
comprehensive laboratory animal monitoring sys-
tem (Columbus Instruments, Columbus, OH, USA) 
as previously described (Chibalin et al., 2008). Mice 
were housed individually with ad libitum access to a 
high fat diet and water. Mice were acclimatized to 
the metabolic cages for 24 hr prior to a 24 hr period 
of automated recordings. Oxygen consumption 
(VO2) and CO2 production were determined by an 
open-circuit Oxymax. Accumulated VO2 was pre-
sented in l/kg/day and energy expenditure was 
reported as heat production divided by kilograms of 
body weight (kcal/kg/day). Ambulatory locomotor 
activity (XAMB) was measured by consecutive beam 
breaks in adjacent beams during a 24 hr period and 
presented as counts/min.
In vivo administration of 1NAPP1
Alk7ASKA and wild type mice (8 weeks old) kept on 
a chow diet were individually caged for 1 week, 
then switched to HFD or kept on a chow diet. 
1NAPP1 was freshly formulated in PEG400 at a 
concentration of 12.5 mg/ml before use. Twice 
daily (9:30 AM and 5:30 PM, respectively) mice on 
HFD received subcutaneous injections of vehicle 
or 1NAPP1 (50 mg/kg/day).
Glucose and insulin tolerance tests
Glucose tolerance tests were performed on animals kept on chow or a high fat diet after overnight 
fasting. Blood glucose was measured by tail tip bleeding using a glucometer (Accutrend; Roche, 
Sweden) at the indicated time points before and after intraperitoneal injection of 2 g/kg (body weight) 
Figure 8. Acute inhibition of ALK7 signaling in adult 
mice reduces diet-induced catecholamine resistance. 
(A) Basal and CL316243 (CL)-stimulated lipolysis in 
adipose tissue biopsies extracted from Alk7ASKA mice 
after 2 weeks on a high fat diet (HFD) treated with 
1NaPP1 (solid bars) or vehicle (open bars). N = 6 mice 
per group. Epi, epididymal; Retro, retroperitoneal.  
(B) Relative mRNA expression levels of Adrb3 assessed 
by Q-PCR in epididymal (Epi) adipose tissue of Alk7ASKA 
mice after chow (open bars) or 2 weeks on HFD treated 
with 1NaPP1 (black bars) or vehicle (gray bars). N = 6 
mice per group. (C–E) Levels of phospho-HSL (p-HSL) 
and phosphorylated PKA (P-PKA) substrates assessed 
by Western blotting in epididymal adipose tissue of 
Alk7ASKA mice after chow or 2 weeks on HFD treated 
with 1NaPP1 or vehicle. Histograms show quantifica-
tion by image analysis of P-HSL levels (D) and levels  
of phosphorylated PKA substrates (E) normalized to 
β-actin levels. N = 4 mice per group. *p < 0.05;  
**p < 0.01; NS, non-significant (1NaPP1 vs vehicle). All 
error bars show mean ± SEM.
DOI: 10.7554/eLife.03245.018
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glucose. Serum insulin was measured from tail blood with an ultrasensitive mouse insulin ELISA kit 
(Mercodia, Sweden). For the insulin tolerance test, mice were fasted for 3 hr, then injected intraperito-
neally with 1.5 IU/kg recombinant human insulin (Humulin R; Lilly, Sweden). Glucose levels were deter-
mined at the indicated time points as above.
Histology
Fresh tissue samples were fixed in 10% formalin, dehydrated, embedded in paraffin, sectioned, 
and stained with hematoxylin and eosin. Photographs of hematoxylin and eosin stained cross-section 
slides were taken with a light microscope. Areas of individual adipocytes were measured with ImageJ 
software (National Institutes of Health) and used for quantification of cell size.
Lipolysis assay
For in vivo lipolysis, mouse tail blood was taken from non-fasted mice for measurement of serum free 
fatty acids before and after intraperitoneal injection of the β3-AR-specific agonist CL316243 (Sigma-
Aldrich, Sweden) (100 μg/kg body weight) at the indicated times (20 min or 40 min). For ex vivo lipolysis, 
epididymal fat pieces weighing about 20 mg were incubated in Krebs–Ringer Bicarbonate Buffer (KRBH) 
containing 1% fatty acid-free BSA (Sigma-Aldrich) and glucose (2.5 mM). The samples were treated with 
either vehicle or CL316243 (1 μM) for 2 hr at 37°C with mild shaking at 150 rpm. After incubation, glyc-
erol release was measured using a free glycerol reagent (Sigma-Aldrich), and normalized to the total 
amount of protein in adipose tissue samples. For in vitro lipolysis in MEF-derived or human adipocytes, 
differentiated adipocytes were washed with KRBH and treated with either vehicle, CL316243 (1 μM), 
Norepinephrine (1 μM), or isoproterenol (1 μM) for 3 hr, and glycerol release was measured as before.
Lipid oxidation
Primary adipocytes were isolated from epididymal adipose tissue after collagenase II (1 mg/ml, Sigma-
Aldrich) digestion, and were incubated with KRBH containing 1% fatty acid-free BSA (Sigma-Aldrich), 
glucose (2.5 mM), palmitic acid (100 μM), and 3H palmitic acid (0.5 μCi/ml). For normalization of counts 
by total protein, an aliquot of adipocytes was snap frozen without BSA and 3H palmitic acid incubation. 
After incubation for 5 hr at 37°C with shaking at 150 rpm, an equal volume of chloroform was added. 
After chloroform separation, 100 μl of the aqueous phase was further mixed with 900 μl 10% activated 
charcoal slurry thoroughly by shaking for 30 min. The mixture was subsequently centrifuged at max-
imum speed at room temperature for 10 min, and 100–200 μl supernatant was taken for assessment 
of 3H counts.
Adipocyte differentiation and treatment
MEFs were prepared from 13.5-day wild type and Alk7 mutant embryos, and differentiated into 
adipocytes according to a standard protocol (Zhang et al., 2009). Briefly, MEF cells were plated at 
about 50–70% confluence on 0.1% gelatin-coated dishes, cultured in DMEM, supplemented with 10% 
fetal bovine serum, 1 mM sodium pyruvate, MEM Non-Essential Amino Acids Solution (Invitrogen, 
Sweden), 0.5 mM 2-mercaptoethanol, and 100 U/ml penicillin and streptomycin (MEF medium). MEF 
monolayers were allowed to grow to confluence before initiation of adipogenesis. Adipogenesis was 
induced by incubation in MEF medium supplemented with 10 μg/ml insulin, 0.5 mM IBMX, 1 μM dex-
amethasone, and 0.5 μM rosiglitazone (adipocyte differentiation medium). After 2 days, the medium 
was changed to MEF medium supplemented with only 10 μg/ml insulin and 0.5 μM rosiglitazone (adi-
pocyte maintenance medium), and then changed again every 2 days until full differentiation (i.e., day 
8–10). Human preadipocytes were purchased from Lonza Biologics and differentiated into adipo-
cytes according to the manufacturer's instructions. For activin B or activin A treatment, cells were incu-
bated with 100 ng/ml activin B or activin A (R&D Systems, UK) in adipocyte maintenance medium for 
48 hr before lipolysis assay or, alternatively, harvested for extraction of RNA and proteins. PPARγ 
agonist rosiglitazone was used at 0.5 μM; PPARγ antagonist T0070907 at 1 μM. Adenovirus particles 
were produced and amplified in HEK293 cells as previously described (Fujii et al., 1999). Adipocytes 
were infected with Adeno-ALK7 or Adeno-LacZ at 2.0 multiplicity of infection (MOI) for 48 hr before 
lipolysis assay or extraction of RNA. For assessment of nuclear p-Smad3, MEF-derived adipocytes 
were incubated for 150 min with 2 μM 1NaPP1 or vehicle (DMSO) then treated for 40 min with 20 ng/ml 
activin B, or left untreated, and fixed with 4% paraformaldehyde. Adipocytes were identified by BODIPY 
493/503 staining and p-Smad3 was assessed by immunocytochemistry with antibodies from Epitomics. 
DAPI was used for nuclear staining. Images were obtained with a Zeiss laser confocal microscope. 
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The intensity of nuclear p-Smad3 was determined using Zen software (Zeiss, Germany) in adipocytes 
from three random fields in three different wells per condition. The number of cells displaying nuclear 
p-Smad3 intensity above an arbitrary threshold was determined in each field, added up for each well, 
and averaged across the three wells of each condition. All values were then normalized to the number 
of responding cells in cultures of wild type adipocytes stimulated with activin B (set to 100). The 
experiment was repeated three times and the results were averaged across the three experiments.
Biochemical assays
Serum triglyceride (Infinity triglyceride reagent; Thermo DMA), free fatty acids (Free Fatty Acids Half 
Micro Test; Roche), leptin (mouse leptin ELISA; Abcam, UK), insulin (Ultrasensitive mouse insulin ELISA; 
Mercodia), and tissue ATP contents (ATPLite; PerkinElmer) were measured with commercial kits 
according to the manufacturer's instructions. For quantification of mitochondria DNA, total adipose 
tissue DNA was extracted with a DNeasy kit (Qiagen, Sweden) and 1 ng was used for Q-PCR quantifi-
cation of the copy number for mitochondrial encoded gene cytochrome B. This was normalized to 
the copy number of the nuclear gene H19. Citrate synthase activity was measured as described (Srere 
et al., 1963) in tissue samples homogenized in RIPA buffer. Epinephrine and norepinephrine were 
measured in adipose tissue extracts by a commercial ELISA kit according to the manufacturer's instruc-
tions (Labor Diagnostika Nord, Sweden). A PKA activity assay was performed with PepTag Non-
Radioactive cAMP-Dependent Protein Kinase Assay (Promega, Sweden).
Tissue isolation, RNA preparation, and quantitative PCR (Q-PCR)
For isolation of adipocyte and stromal-vascular fractions (SVF), tissues were dissected from epididymal 
depots of 8-week-old mice, minced with forceps in PBS, and washed three times with 0.1% BSA KRBH. 
Digestion was carried out for 90–120 min in 2% BSA KRBH containing 0.2 mg/ml collagenase II (Sigma-
Aldrich) with constant agitation. Digested tissue was filtered through 250 μm nylon mesh and centri-
fuged for 10 min at 1000 rpm (200×g) to separate floating adipocytes. The supernatant and the pellet 
were further centrifuged for 10 min at 1500 rpm (240×g). The resulting pellet (SVF) and the adipocytes 
were resuspended in lysis buffer and kept at −80°C. ‘Browning’ of subcutaneous adipose tissue was 
induced by chronic treatment with CL316243. A number of 12–16-week-old mice were injected daily 
intraperitoneally with either 1 mg/kg CL316243 (Sigma) or PBS only (vehicle) for 7 days. Inguinal sub-
cutaneous adipose tissue was isolated from these mice. Total RNA from tissues or cells was isolated 
with an RNAeasy kit (Qiagen) according to the manufacturer's instructions. Isolated RNA samples were 
digested with DNase prior to reverse transcription with Superscript II (Invitrogen). Q-PCR of cDNA 
samples was performed on a ABI StepOne Plus instrument (Applied Biosystems, Sweden) using SYBR 
Green master mix (Applied Biosystems) and primers as indicated in Supplementary file 1.
Cell transfection and luciferase assay
The R4-2 cell line is a derivative of MvLu1 mink lung epithelial cells that expresses low levels 
of type 1 TGF-β receptors (Andersson et al., 2008). R4-2 cells were cultured in 24-well plates in 
DMEM medium supplemented with 10% serum and antibiotics. They were transfected using 
Lipofectamine 2000 (Invitrogen) with expression plasmids carrying wild type or Aska variants of 
the rat Alk7 cDNA, the Smad3-dependent luciferase reporter plasmid CAGA-Luc (Dennler et al., 
1998), and a Renilla plasmid for normalization. At 24 hr after transfection, cells were stimulated 
with 25 ng/ml activin B together with 1 μM 2NaPP1 (solubilized in DMSO) or DMSO only (vehicle). 
Then 24 hr after stimulation, luciferase activity was analyzed using the Dual-Luciferase Reporter 
Assay System (Promega) in a 1450 Microbeta Jet counter (Wallac). For assays of p-Smad2 by 
Western blotting, cells were treated 48 hr after transfection with 1 μM 2NaPP1 for 3 hr prior to 
addition of 25 ng/ml activin B for an additional hour. Monolayers were then processed for Western 
blotting as described below.
Western blot analysis
Protein extraction and Western blotting were performed according to standard protocols. Briefly, 
snap-frozen adipose tissue or cell samples were homogenized in ice-cold RIPA buffer (50 mM Tris–HCl 
pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM sodium chloride, 1 mM EDTA) containing 
1 mM sodium orthovanadate, 1 mM sodium fluoride, and proteinase inhibitor cocktail (Roche), and 
centrifuged at 13,000×g for 15 min to collect supernatants. Supernatants (30 μg protein) were used 
for reducing SDS PAGE and Western blotting. Primary antibodies against p-HSL, HSL, p-PKA substrates, 
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p-Perilipin, p-Smad2, β-actin, and α-tubulin (Cell Signaling, Sweden) were used at 1:2000 dilution. The 
levels of target proteins were quantified by the intensity of Western blot bands using ImageJ software 
(National Institutes of Health).
Statistical analysis
Statistical significance was determined by using unpaired two-tailed or one-tailed Student's t tests and 
one-way ANOVA. Differences were considered significant at a p value less than 0.05. Quantified data 
are presented as mean ± SEM.
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